Skip to main content
VCbacked
Log inGet Started

Oculomotor Technologies

Newark, United States

Oculomotor Technologies offers a vision therapy tool for optometry practices to treat convergence insufficiency.

$75K raised
Oct 2024
Grant
Health CareInformation TechnologyVirtual Reality

Top Investors

National Science FoundationCommission on ScienceInnovation and Technology

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Oculomotor Technologies

How much funding has Oculomotor Technologies raised?
Oculomotor Technologies has raised $75K in total funding. The most recent round was Grant. The last funding was announced in October 2024.
Who are Oculomotor Technologies's investors?
Oculomotor Technologies's investors include National Science Foundation, Commission on Science, Innovation and Technology.
Where is Oculomotor Technologies headquartered?
Oculomotor Technologies is headquartered in Newark, United States.
What does Oculomotor Technologies do?
Oculomotor Technologies offers a vision therapy tool for optometry practices to treat convergence insufficiency.
What stage is Oculomotor Technologies at?
Oculomotor Technologies is at the Grant stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Oculomotor Technologies — Funding & Investors." VCBacked, October 15, 2024, https://www.vcbacked.co/company/oculomotor-technologies. Accessed July 2, 2026.
APA
VCBacked. (2024). Oculomotor Technologies — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/oculomotor-technologies
Wikipedia (cite web)
{{cite web |title=Oculomotor Technologies — Funding & Investors |url=https://www.vcbacked.co/company/oculomotor-technologies |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Health Care

View all
Rapport Therapeutics
Boston$250.0M
Oryl Photonics
Lausanne
Allterum Therapeutics
Houston$1.0M
OncoRevive
Brunswick$119K
YLAH
Bern$589K
Novostia
Epalinges$6.6M